{
    "id": 18484,
    "fullName": "TTK C604Y",
    "impact": "missense",
    "proteinEffect": "no effect - predicted",
    "geneVariantDescriptions": [
        {
            "description": "TTK (MPS1) C604Y lies within the kinase domain of the Ttk (Mps1) protein (UniProt.org). C604Y confers resistance to Mps1 inhibitors by preventing binding to the Ttk (Mps1) protein, but otherwise has activity similar to wild-type (PMID: 26364596).",
            "references": [
                {
                    "id": 295,
                    "pubMedId": null,
                    "title": null,
                    "url": "https://www.uniprot.org"
                },
                {
                    "id": 4449,
                    "pubMedId": 26364596,
                    "title": "Molecular basis underlying resistance to Mps1/TTK inhibitors.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/26364596"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 7272,
        "geneSymbol": "TTK",
        "terms": [
            "TTK",
            "CT96",
            "ESK",
            "MPH1",
            "MPS1",
            "MPS1L1",
            "PYT"
        ]
    },
    "variant": "C604Y",
    "createDate": "02/23/2016",
    "updateDate": "05/24/2018",
    "referenceTranscriptCoordinates": {
        "id": 122053,
        "transcript": "NM_003318",
        "gDna": "chr6:g.80035304G>A",
        "cDna": "c.1811G>A",
        "protein": "p.C604Y",
        "sourceDb": "RefSeq",
        "refGenomeBuild": "GRCh38/hg38"
    },
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 4702,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, a colon cancer cell line harboring TTK C604Y demonstrated resistance to inhibition by AZ3146 in culture (PMID: 26364596).",
            "molecularProfile": {
                "id": 18826,
                "profileName": "TTK C604Y"
            },
            "therapy": {
                "id": 3117,
                "therapyName": "AZ3146",
                "synonyms": null
            },
            "indication": {
                "id": 219,
                "name": "colon cancer",
                "source": "DOID"
            },
            "responseType": "resistant",
            "references": [
                {
                    "id": 4449,
                    "pubMedId": 26364596,
                    "title": "Molecular basis underlying resistance to Mps1/TTK inhibitors.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/26364596"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 4713,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, a colon cancer cell line harboring TTK C604Y demonstrated resistance to inhibition by MPI-0479605 in culture (PMID: 26364596).",
            "molecularProfile": {
                "id": 18826,
                "profileName": "TTK C604Y"
            },
            "therapy": {
                "id": 3458,
                "therapyName": "MPI-0479605",
                "synonyms": null
            },
            "indication": {
                "id": 219,
                "name": "colon cancer",
                "source": "DOID"
            },
            "responseType": "resistant",
            "references": [
                {
                    "id": 4449,
                    "pubMedId": 26364596,
                    "title": "Molecular basis underlying resistance to Mps1/TTK inhibitors.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/26364596"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 4711,
            "approvalStatus": "Preclinical",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, a colon cancer cell line harboring TTK C604Y demonstrated sensitivity to inhibition by reversine in culture (PMID: 26364596).",
            "molecularProfile": {
                "id": 18826,
                "profileName": "TTK C604Y"
            },
            "therapy": {
                "id": 2327,
                "therapyName": "Reversine",
                "synonyms": null
            },
            "indication": {
                "id": 219,
                "name": "colon cancer",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 4449,
                    "pubMedId": 26364596,
                    "title": "Molecular basis underlying resistance to Mps1/TTK inhibitors.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/26364596"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 4696,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, a colon cancer cell line harboring TTK C604Y demonstrated resistance to inhibition by Cpd-5 in culture (PMID: 26364596).",
            "molecularProfile": {
                "id": 18826,
                "profileName": "TTK C604Y"
            },
            "therapy": {
                "id": 3465,
                "therapyName": "Cpd-5",
                "synonyms": null
            },
            "indication": {
                "id": 219,
                "name": "colon cancer",
                "source": "DOID"
            },
            "responseType": "resistant",
            "references": [
                {
                    "id": 4449,
                    "pubMedId": 26364596,
                    "title": "Molecular basis underlying resistance to Mps1/TTK inhibitors.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/26364596"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 4706,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, a colon cancer cell line harboring TTK C604Y demonstrated resistance to inhibition by MPS1-IN-3 in culture (PMID: 26364596).",
            "molecularProfile": {
                "id": 18826,
                "profileName": "TTK C604Y"
            },
            "therapy": {
                "id": 3455,
                "therapyName": "MPS1-IN-3",
                "synonyms": null
            },
            "indication": {
                "id": 219,
                "name": "colon cancer",
                "source": "DOID"
            },
            "responseType": "resistant",
            "references": [
                {
                    "id": 4449,
                    "pubMedId": 26364596,
                    "title": "Molecular basis underlying resistance to Mps1/TTK inhibitors.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/26364596"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 4697,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, a colon cancer cell line harboring TTK C604Y demonstrated resistance to inhibition by NMS-P715 in culture (PMID: 26364596).",
            "molecularProfile": {
                "id": 18826,
                "profileName": "TTK C604Y"
            },
            "therapy": {
                "id": 3107,
                "therapyName": "NMS-P715",
                "synonyms": null
            },
            "indication": {
                "id": 219,
                "name": "colon cancer",
                "source": "DOID"
            },
            "responseType": "resistant",
            "references": [
                {
                    "id": 4449,
                    "pubMedId": 26364596,
                    "title": "Molecular basis underlying resistance to Mps1/TTK inhibitors.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/26364596"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 18826,
            "profileName": "TTK C604Y",
            "profileTreatmentApproaches": [
                {
                    "id": 7881,
                    "name": "Reversine",
                    "profileName": "TTK C604Y"
                }
            ]
        }
    ],
    "allTranscriptCoordinates": [
        {
            "id": 122054,
            "transcript": "XM_011536099",
            "gDna": "chr6:g.80035304G>A",
            "cDna": "c.1811G>A",
            "protein": "p.C604Y",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 122053,
            "transcript": "NM_003318",
            "gDna": "chr6:g.80035304G>A",
            "cDna": "c.1811G>A",
            "protein": "p.C604Y",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        }
    ]
}